Does IXEKIZUMAB Cause Injection site urticaria? 652 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 652 reports of Injection site urticaria have been filed in association with IXEKIZUMAB (TALTZ). This represents 1.9% of all adverse event reports for IXEKIZUMAB.
652
Reports of Injection site urticaria with IXEKIZUMAB
1.9%
of all IXEKIZUMAB reports
0
Deaths
10
Hospitalizations
How Dangerous Is Injection site urticaria From IXEKIZUMAB?
Of the 652 reports, 10 (1.5%) required hospitalization, and 1 (0.2%) were considered life-threatening.
Is Injection site urticaria Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IXEKIZUMAB. However, 652 reports have been filed with the FAERS database.
What Other Side Effects Does IXEKIZUMAB Cause?
Injection site pain (3,799)
Psoriasis (2,818)
Drug ineffective (2,759)
Injection site erythema (2,144)
Injection site reaction (1,701)
Injection site swelling (1,615)
Incorrect dose administered (1,032)
Covid-19 (861)
Product dose omission issue (832)
Therapy interrupted (796)
What Other Drugs Cause Injection site urticaria?
DUPILUMAB (3,104)
ETANERCEPT (2,780)
ADALIMUMAB (2,188)
GLATIRAMER (1,091)
TIRZEPATIDE (842)
EVOLOCUMAB (486)
GALCANEZUMAB-GNLM (478)
DULAGLUTIDE (450)
HUMIRA (346)
ANAKINRA (314)
Which IXEKIZUMAB Alternatives Have Lower Injection site urticaria Risk?
IXEKIZUMAB vs JAKAFI
IXEKIZUMAB vs JANUMET
IXEKIZUMAB vs JANUVIA
IXEKIZUMAB vs JETREA
IXEKIZUMAB vs JUXTAPID